Codexis, Inc. – LSE:0I0X.L
Codexis stock price today
Codexis stock price monthly change
Codexis stock price quarterly change
Codexis stock price yearly change
Codexis key metrics
Market Cap | 403.63M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -0.93 |
Revenue | 74.23M |
EBITDA | -23.15M |
Income | -65.12M |
Revenue Q/Q | 31.51% |
Revenue Y/Y | -36.13% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -31.19% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCodexis stock price history
Codexis stock forecast
Codexis financial statements
| Jun 2023 | 21.32M | -11.52M | -54.04% |
|---|---|---|---|
| Sep 2023 | 9.27M | -34.90M | -376.29% |
| Dec 2023 | 26.56M | -7.19M | -27.08% |
| Mar 2024 | 17.07M | -11.50M | -67.39% |
| Dec 2023 | 26.56M | -7.19M | -27.08% |
|---|---|---|---|
| Mar 2024 | 17.07M | -11.50M | -67.39% |
| Sep 2025 | 16.36M | -12.57M | -76.84% |
| Dec 2025 | 19.43M | -10.89M | -56.08% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 206761000 | 82.63M | 39.96% |
|---|---|---|---|
| Sep 2023 | 154455000 | 62.94M | 40.76% |
| Dec 2023 | 136561000 | 49.94M | 36.57% |
| Mar 2024 | 149559000 | 70.29M | 47% |
| Jun 2023 | -16.08M | -1.57M | 6.92M |
|---|---|---|---|
| Sep 2023 | -16.30M | -1.10M | -108K |
| Dec 2023 | -11.03M | 1.10M | 0 |
| Mar 2024 | -7.78M | -28.56M | 29.28M |
Codexis alternative data
| Aug 2023 | 248 |
|---|---|
| Sep 2023 | 248 |
| Oct 2023 | 248 |
| Nov 2023 | 248 |
| Dec 2023 | 248 |
| Jan 2024 | 248 |
| Feb 2024 | 248 |
| Mar 2024 | 174 |
| Apr 2024 | 174 |
| May 2024 | 174 |
| Jun 2024 | 174 |
| Jul 2024 | 174 |
Codexis other data
-
What's the price of Codexis stock today?
One share of Codexis stock can currently be purchased for approximately $4.79.
-
When is Codexis's next earnings date?
Unfortunately, Codexis's (0I0X.L) next earnings date is currently unknown.
-
Does Codexis pay dividends?
No, Codexis does not pay dividends.
-
How much money does Codexis make?
Codexis has a market capitalization of 403.63M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 49.39% to 70.14M US dollars.
-
What is Codexis's stock symbol?
Codexis, Inc. is traded on the LSE under the ticker symbol "0I0X.L".
-
What is Codexis's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Codexis?
Shares of Codexis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Codexis have?
As Jul 2024, Codexis employs 174 workers.
-
When Codexis went public?
Codexis, Inc. is publicly traded company for more then 7 years since IPO on 29 Jan 2018.
-
What is Codexis's official website?
The official website for Codexis is codexis.com.
-
Where are Codexis's headquarters?
Codexis is headquartered at 200 Penobscot Drive, Redwood City, CA.
-
How can i contact Codexis?
Codexis's mailing address is 200 Penobscot Drive, Redwood City, CA and company can be reached via phone at +65 04218100.
Codexis company profile:
Codexis, Inc.
codexis.comLSE
174
Biotechnology
Healthcare
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Redwood City, CA 94063
:
ISIN: US1920051067
:
